Skip to content
healthcare.dev

Levothyroxine sodium

NDC 87063-093, Levothyroxine Sodium, tablet, from ASCLEMED USA INC..

Product NDC
87063-093
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212399
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-093 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM200 ug/1

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
87063-093-00870630093001000 TABLET in 1 BOTTLE (87063-093-00)
87063-093-308706300933030 TABLET in 1 BOTTLE (87063-093-30)
87063-093-608706300936060 TABLET in 1 BOTTLE (87063-093-60)
87063-093-908706300939090 TABLET in 1 BOTTLE (87063-093-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/42a26f8a-dc67-42e4-abb0-d2602afb1b7d

Use it

Look up 87063-093 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-093 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-093. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.